takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Masato Iwasaki Ph.D.
Director and President of Japan Pharma Business Unit ,Takeda Pharmaceutical Company Limited
|Age||Total Calculated Compensation||This person is connected to 18 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Masato Iwasaki has been President of Japan Pharma Business Unit at Takeda Pharmaceutical Company Limited. Mr. Iwasaki served as Senior Vice President of Pharmaceutical Marketing Division at Takeda Pharmaceutical Company Limited since April 1, 2012. He served as Vice President of Human Resources Management Department - Pharmaceutical Marketing Division at Takeda Pharmaceutical Company Ltd. He served as Senior Vice President of Strategic Product Planning Department ...
12-10, Nihonbashi 2-chomePhone: 81 3 3278 2111
Osaka, -- 103-8668
Fax: 81 3 3278 2000
Board Members Memberships*
Director and President of Japan Pharma Business Unit
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Vincent A. Forlenza||Chairman, Chief Executive Officer and President|
Becton, Dickinson and Company
|Yitzhak Peterburg M.D., Dr.P.H., MSc||Interim Chief Executive Officer, Interim President and Director|
Teva Pharmaceutical Industries Limited
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Executive Director|
|Stefan Oschmann||Chairman of Executive Board, Chief Executive Officer and Chairman of Corporate Responsibility Committee|
Merck Kommanditgesellschaft auf Aktien
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma Inc.
|¥216.0M||Compensation as of Fiscal Year 2016.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.